This review highlights the potential roles and future applications of targeting the Ang–TIE signaling pathway in AADs involving atherosclerosis, cardiovascular diseases, chronic kidney disease, diabetic vascular complications and Alzheimer’s disease. This evidence concerns the gene ANG and Alzheimer disease.